Institute of Oncology "Angel H Roffo"

What Institute of Oncology "Angel H Roffo" does

The Instituto de Oncología Ángel H. Roffo is a public academic oncology institute affiliated with the Universidad de Buenos Aires (UBA), located in Buenos Aires, Argentina. Named after Angel Honorio Roffo, a pioneer in Argentine oncology, the institute operates as UBA's primary oncology teaching and research center and serves cancer patients through Argentina's public healthcare system. The institution treats over 100 cancer types spanning solid tumors and hematologic malignancies, including carcinomas, sarcomas, leukemias, lymphomas, multiple myeloma, and melanoma.

The institute delivers comprehensive cancer care across nine specialized departments — Medical Area, Surgical Area, Radiation Therapy and Nuclear Medicine, Diagnostic Imaging, Diagnostic (pathology/laboratory), Research, Technical, Strategic Management and Medical Audit, and Nursing — and additional governance committees covering clinical research ethics, teaching, and laboratory animal care. Service breadth spans open and laparoscopic surgical oncology, chemotherapy, hormone therapy, targeted therapies including monoclonal antibodies, external beam radiation and brachytherapy, nuclear medicine including PET-CT, and diagnostic imaging using CT, MRI, and scintigraphy. Beyond clinical care, the institute runs a nursing school, residency and rotation programs, and a social volunteer program in palliative care. It publishes the Pautas en Oncología clinical guidelines (2018, 2023) that establish treatment standards for Argentina's healthcare system, maintains a Digital Library (Biblioteca Digital) and Press Office, and operates a wholly owned Fundación (Foundation) supporting research and patient care.

Revenue flows primarily through Argentina's public healthcare system via government funding and public system reimbursements, supplemented by educational and research grants from UBA and research funders. Pricing is determined by public health system protocols rather than commercial negotiation, and the institute explicitly provides guidance for patients without medical coverage. Marketing and patient acquisition rely on the institutional website (institutoroffo.uba.ar), Instagram, an electronic newsletter, and earned media through the press office; patient intake runs through physician referrals, public system referrals, and a direct appointment system (turnos telefónicos and email). No venture capital, private equity, or individual ownership is indicated; the entity is structured as a government state entity within UBA's public university framework.

Name

Institute of Oncology "Angel H Roffo"

Legal name

Instituto de Oncología Ángel H. Roffo

Website

https://institutoroffo.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Public UBA-affiliated oncology institute in Buenos Aires delivering comprehensive cancer diagnosis, treatment, research, and medical education across nine specialized departments to Argentina's public healthcare system.

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYHLAFAHAC

Oncology & Cancer Specialty Hospitals

Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care

Keywords

• Cancer treatment services
• Oncology medical care
• Radiation therapy services
• Clinical oncology research
• Medical residency training

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Healthcare Services Revenue: As a public institution affiliated with Universidad de Buenos Aires, the institute operates as part of Argentina's public healthcare system. Revenue is generated through government healthcare funding, public system reimbursements, and services to patients. The institute also conducts research and academic activities funded through educational and research grants.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

The Instituto de Oncología Ángel H. Roffo is a public oncology institute affiliated with Universidad de Buenos Aires (UBA) that delivers comprehensive cancer care — including medical oncology, surgical oncology, radiation therapy, nuclear medicine, diagnostic imaging, and laboratory diagnostics — alongside oncology research, residency and nursing education programs, and nationally published clinical guidelines for cancer treatment protocols in Argentina.

Product overview

The Instituto de Oncología Ángel H. Roffo is an oncology institute affiliated with the University of Buenos Aires (UBA) offering a comprehensive range of cancer care services. The institution operates through multiple specialized areas including medical oncology, surgical oncology, radiation therapy and nuclear medicine, diagnostic imaging, and diagnostic laboratory services. Additional support services include clinical research, ethics oversight, nursing education, and palliative care volunteer programs. The institute also publishes oncology clinical guidelines (Pautas en Oncología) for treatment standardization.

Differentiator

Problem solved

Functional benefit

Products and services

• Área Médica (Medical Oncology Area)

Quantifiable outcome

• Comprehensive oncology care across 9+ specialized departments
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Universidad de Buenos Aires (UBA)coreStrategic or Co-development PartnerAcademic affiliation with Universidad de Buenos Aires as the parent educational institution. The institute operates as the oncology teaching and research center for UBA's medical school. This partnership provides access to academic resources, medical talent through residency programs, research capabilities, and institutional credibility. The institute publishes clinical guidelines under the UBA affiliation.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• European Institute of Oncology (IEO): Milan-based integrated cancer specialty center combining surgery, medical oncology, radiation, diagnostics, and research. Comparable as a single-site comprehensive cancer specialty institution with strong academic ties.
• A.C. Camargo Cancer Center: Brazilian comprehensive cancer specialty center integrating medical, surgical, radiation oncology, diagnostics, research, and teaching under one institution. Highly comparable in scope, mission, and Latin American public-health orientation to Roffo.
• Instituto Nacional de Cancerología (Colombia): Colombia's national public oncology institute providing multi-modality cancer care, residency training, and clinical research — directly comparable as a publicly funded, academically anchored cancer specialty institution in Latin America.

Regional players

• Instituto Nacional de Cancerología (Mexico): Mexican federal reference cancer center providing multi-modality treatment, research, and training. Comparable as a publicly funded national oncology specialty hospital in a neighboring Latin American market.
• Hospital Italiano de Buenos Aires: Large Argentine academic hospital with an established oncology program serving both private and social-security patients. Comparable as a Buenos Aires academic provider with competing oncology capabilities but broader non-oncology scope.
• Hospital Alemán de Buenos Aires: Buenos Aires private community-academic hospital with oncology services. Comparable as a Buenos Aires-based provider competing for the same metropolitan oncology patient pool.
• Hospital de Clínicas José de San Martín (UBA): Sibling UBA-affiliated academic hospital in Buenos Aires with general and specialty services including oncology. Comparable as a same-parent, same-city academic teaching hospital that overlaps on patient pool and faculty.

Broad incumbents

• MD Anderson Cancer Center: Globally leading academic cancer specialty hospital with comprehensive multi-modality care, residency programs, and guideline-grade research output. Comparable in mission and service breadth but at vastly greater scale and US-centric funding model.
• Memorial Sloan Kettering Cancer Center: US-based academic cancer specialty center delivering integrated oncology care, training, and research publications. Comparable in being a teaching/research-driven specialty hospital, though at much larger scale and private/nonprofit status.

Others

• Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI): Argentine non-profit specialty medical institution combining clinical care, research, and residency training. Comparable as an Argentine academic specialty non-profit with integrated teaching and clinical operations, though focused on neurology rather than oncology.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/institutoroffo
• LinkedInlinkedin.com/company/institute-of-oncology-angel-h-roffo-

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of Oncology "Angel H Roffo"